| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 1.73e-05 | 40 | 162 | 5 | GO:0140662 | |
| MousePheno | abnormal chorioallantoic fusion | 2.19e-06 | 90 | 133 | 8 | MP:0002824 | |
| MousePheno | abnormal allantois morphology | 1.13e-05 | 112 | 133 | 8 | MP:0001726 | |
| MousePheno | abnormal placenta development | 2.18e-05 | 160 | 133 | 9 | MP:0001712 | |
| MousePheno | abnormal placenta physiology | SUPT20HL1 ASH1L SUPT20HL2 PTK2 PIGQ IPO9 UBR5 TMED2 NIPBL CRB2 | 2.50e-05 | 204 | 133 | 10 | MP:0010038 |
| MousePheno | abnormal extraembryonic tissue physiology | SUPT20HL1 UBR4 ASH1L SUPT20HL2 TEK BIRC6 PTK2 PIGQ IPO9 UBR5 TMED2 NIPBL CRB2 | 2.50e-05 | 345 | 133 | 13 | MP:0004264 |
| Domain | - | STK36 RIPOR2 CIP2A SCYL3 TOGARAM1 TMCO6 HEATR5A AP3B1 IPO9 TELO2 UTP20 PRKDC NIPBL | 4.64e-08 | 222 | 156 | 13 | 1.25.10.10 |
| Domain | ARM-type_fold | STK36 RIPOR2 CIP2A UBR4 SCYL3 TOGARAM1 TMCO6 HEATR5A AP3B1 URB1 IPO9 TELO2 UTP20 PRKDC NIPBL | 1.68e-07 | 339 | 156 | 15 | IPR016024 |
| Domain | ARM-like | STK36 RIPOR2 CIP2A SCYL3 TOGARAM1 TMCO6 HEATR5A AP3B1 IPO9 TELO2 UTP20 PRKDC NIPBL | 4.47e-07 | 270 | 156 | 13 | IPR011989 |
| Domain | LMBR1 | 2.27e-06 | 4 | 156 | 3 | PF04791 | |
| Domain | LMBR1-like_membr_prot | 2.27e-06 | 4 | 156 | 3 | IPR006876 | |
| Domain | HEAT | 8.72e-06 | 58 | 156 | 6 | IPR000357 | |
| Domain | HEAT_REPEAT | 2.60e-05 | 70 | 156 | 6 | PS50077 | |
| Domain | ACTININ_2 | 3.66e-05 | 23 | 156 | 4 | PS00020 | |
| Domain | ACTININ_1 | 3.66e-05 | 23 | 156 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 3.66e-05 | 23 | 156 | 4 | IPR001589 | |
| Domain | LIMR | 6.93e-05 | 2 | 156 | 2 | IPR008075 | |
| Domain | - | 1.19e-04 | 12 | 156 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.19e-04 | 12 | 156 | 3 | IPR029047 | |
| Domain | - | 1.54e-04 | 13 | 156 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.54e-04 | 13 | 156 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.54e-04 | 13 | 156 | 3 | IPR029048 | |
| Domain | Cadherin_2 | 2.10e-04 | 65 | 156 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.10e-04 | 65 | 156 | 5 | IPR013164 | |
| Domain | HSP70 | 2.96e-04 | 16 | 156 | 3 | PF00012 | |
| Domain | Cadherin_CS | 3.08e-04 | 109 | 156 | 6 | IPR020894 | |
| Domain | HSP70_2 | 3.57e-04 | 17 | 156 | 3 | PS00329 | |
| Domain | HSP70_1 | 3.57e-04 | 17 | 156 | 3 | PS00297 | |
| Domain | HSP70_3 | 3.57e-04 | 17 | 156 | 3 | PS01036 | |
| Domain | CADHERIN_1 | 3.73e-04 | 113 | 156 | 6 | PS00232 | |
| Domain | Cadherin | 3.73e-04 | 113 | 156 | 6 | PF00028 | |
| Domain | CADHERIN_2 | 3.92e-04 | 114 | 156 | 6 | PS50268 | |
| Domain | - | 3.92e-04 | 114 | 156 | 6 | 2.60.40.60 | |
| Domain | CA | 4.10e-04 | 115 | 156 | 6 | SM00112 | |
| Domain | Hsp_70_fam | 4.25e-04 | 18 | 156 | 3 | IPR013126 | |
| Domain | Cadherin-like | 4.30e-04 | 116 | 156 | 6 | IPR015919 | |
| Domain | MFS_1 | 4.64e-04 | 77 | 156 | 5 | PF07690 | |
| Domain | MFS | 4.64e-04 | 77 | 156 | 5 | IPR011701 | |
| Domain | Cadherin | 4.71e-04 | 118 | 156 | 6 | IPR002126 | |
| Domain | HEAT | 6.85e-04 | 48 | 156 | 4 | PF02985 | |
| Domain | MFS_dom | 9.19e-04 | 134 | 156 | 6 | IPR020846 | |
| Domain | ZnF_UBR1 | 1.42e-03 | 7 | 156 | 2 | SM00396 | |
| Domain | ZF_UBR | 1.42e-03 | 7 | 156 | 2 | PS51157 | |
| Domain | zf-UBR | 1.42e-03 | 7 | 156 | 2 | PF02207 | |
| Domain | Znf_UBR | 1.42e-03 | 7 | 156 | 2 | IPR003126 | |
| Domain | BIR | 1.88e-03 | 8 | 156 | 2 | PF00653 | |
| Domain | BIR_REPEAT_2 | 1.88e-03 | 8 | 156 | 2 | PS50143 | |
| Domain | BIR | 1.88e-03 | 8 | 156 | 2 | SM00238 | |
| Domain | Calx_beta | 1.88e-03 | 8 | 156 | 2 | SM00237 | |
| Domain | - | 1.88e-03 | 8 | 156 | 2 | 1.10.1170.10 | |
| Domain | BIR_rpt | 1.88e-03 | 8 | 156 | 2 | IPR001370 | |
| Domain | BIR_REPEAT_1 | 1.88e-03 | 8 | 156 | 2 | PS01282 | |
| Domain | MFS | 2.13e-03 | 108 | 156 | 5 | PS50850 | |
| Domain | CH | 2.13e-03 | 65 | 156 | 4 | SM00033 | |
| Domain | Calx_beta | 2.40e-03 | 9 | 156 | 2 | IPR003644 | |
| Domain | rSAM | 2.40e-03 | 9 | 156 | 2 | IPR007197 | |
| Domain | Radical_SAM | 2.40e-03 | 9 | 156 | 2 | PF04055 | |
| Domain | Calx-beta | 2.40e-03 | 9 | 156 | 2 | PF03160 | |
| Domain | CH | 2.80e-03 | 70 | 156 | 4 | PF00307 | |
| Domain | - | 2.95e-03 | 71 | 156 | 4 | 1.10.418.10 | |
| Domain | VIT | 2.99e-03 | 10 | 156 | 2 | PS51468 | |
| Domain | VIT | 2.99e-03 | 10 | 156 | 2 | IPR013694 | |
| Domain | CH | 3.26e-03 | 73 | 156 | 4 | PS50021 | |
| Domain | CH-domain | 3.59e-03 | 75 | 156 | 4 | IPR001715 | |
| Domain | LAM_G_DOMAIN | 3.89e-03 | 38 | 156 | 3 | PS50025 | |
| Domain | UBX | 4.33e-03 | 12 | 156 | 2 | SM00166 | |
| Domain | Laminin_G_2 | 4.50e-03 | 40 | 156 | 3 | PF02210 | |
| Domain | UBX_dom | 5.09e-03 | 13 | 156 | 2 | IPR001012 | |
| Domain | UBX | 5.09e-03 | 13 | 156 | 2 | PF00789 | |
| Domain | UBX | 5.09e-03 | 13 | 156 | 2 | PS50033 | |
| Domain | Cadherin_C | 5.17e-03 | 42 | 156 | 3 | IPR032455 | |
| Domain | Cadherin_C_2 | 5.17e-03 | 42 | 156 | 3 | PF16492 | |
| Domain | LamG | 5.89e-03 | 44 | 156 | 3 | SM00282 | |
| Domain | Dynein_HC_stalk | 5.91e-03 | 14 | 156 | 2 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.91e-03 | 14 | 156 | 2 | IPR013602 | |
| Domain | DHC_N2 | 5.91e-03 | 14 | 156 | 2 | PF08393 | |
| Domain | MT | 5.91e-03 | 14 | 156 | 2 | PF12777 | |
| Domain | Tyr_kinase_cat_dom | 6.34e-03 | 88 | 156 | 4 | IPR020635 | |
| Domain | TyrKc | 6.34e-03 | 88 | 156 | 4 | SM00219 | |
| Domain | DHC_fam | 6.78e-03 | 15 | 156 | 2 | IPR026983 | |
| Domain | Dynein_heavy | 6.78e-03 | 15 | 156 | 2 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.78e-03 | 15 | 156 | 2 | IPR004273 | |
| Domain | AAA | 7.24e-03 | 144 | 156 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 7.24e-03 | 144 | 156 | 5 | IPR003593 | |
| Domain | - | 8.28e-03 | 95 | 156 | 4 | 2.60.120.200 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19136951 | ||
| Pubmed | LMBRD1: the gene for the cblF defect of vitamin B₁₂ metabolism. | 1.01e-07 | 3 | 163 | 3 | 20446115 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | FLNA HYOU1 CIP2A UBR4 PEX1 LMBR1 LRRC40 AP3B1 FANCD2 URB1 IPO9 LMBR1L UBR5 TELO2 NUP210 UTP20 PRKDC VARS1 CAPN15 | 1.06e-07 | 942 | 163 | 19 | 31073040 |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | FLNA UBR4 LCP1 CREG1 BIRC6 ARPC1B IPO9 PRKDC VARS1 HSPA9 SEC23B | 7.60e-07 | 344 | 163 | 11 | 30333137 |
| Pubmed | A2M HSPG2 FLNA EVC2 PSAP CPXM2 HLA-B UBR4 ASH1L LAMA4 HIPK3 PIGQ SUSD1 UBR5 | 8.55e-07 | 591 | 163 | 14 | 15231748 | |
| Pubmed | FLNA HYOU1 CIP2A UBR4 LRRC40 AP3B1 IPO9 TELO2 NUP210 PKN2 PRKDC VARS1 HSPA8 HSPA9 | 2.09e-06 | 638 | 163 | 14 | 33239621 | |
| Pubmed | FLNA HYOU1 UBR4 LCP1 LARP4 BIRC6 URB1 UBR5 NUP210 UTP20 PRKDC NIPBL HSPA9 SEC23B | 2.73e-06 | 653 | 163 | 14 | 22586326 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | HLA-B CIP2A BIRC6 ARPC1B FANCD2 URB1 UBR5 TELO2 PRKDC VARS1 HSPA8 HSPA9 SEC23B | 3.29e-06 | 571 | 163 | 13 | 37167062 |
| Pubmed | 3.43e-06 | 49 | 163 | 5 | 21362503 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | A2M FLNA HYOU1 CIP2A UBR4 LCP1 AP3B1 ELP3 FANCD2 SEPSECS UBR5 TELO2 NUP210 PRKDC PLS1 VARS1 SNTA1 | 3.65e-06 | 974 | 163 | 17 | 28675297 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | VWA5B2 HSPG2 FLNA STK36 ABCA2 SZT2 CTC1 UBR4 AKNA TMCO6 PANX1 BIRC6 MXRA7 ARHGEF10L TLNRD1 URB1 CLN3 PRKDC | 4.83e-06 | 1105 | 163 | 18 | 35748872 |
| Pubmed | Evidence that the transcriptional repressor ICER is regulated via the N-end rule for ubiquitination. | 8.72e-06 | 28 | 163 | 4 | 35227662 | |
| Pubmed | FLNA ABCA2 HYOU1 HLA-B UBR4 AKNA LRRC40 PANX1 MSH3 AP3B1 LARP4 BIRC6 IPO9 UBR5 NUP210 PRKDC LMBRD1 HSPA8 | 1.03e-05 | 1168 | 163 | 18 | 19946888 | |
| Pubmed | 1.53e-05 | 233 | 163 | 8 | 37704626 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | FLNA PSAP HYOU1 UBR4 AP3B1 ELP3 BIRC6 ARPC1B FANCD2 IPO9 TELO2 NFRKB PRKDC HSF1 PLS1 VARS1 HSPA8 HSPA9 SEC23B RABGGTA | 1.70e-05 | 1455 | 163 | 20 | 22863883 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | FLNA EXO5 STRIP1 FANCD2 ZBTB7A SLC41A3 CLN3 NFRKB UTP20 PKN2 PRKDC HSF1 NIPBL HSPA8 | 1.85e-05 | 774 | 163 | 14 | 15302935 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | FLNA UBR4 LRRC40 MSH3 LARP4 ELP3 BIRC6 ARPC1B PTK2 URB1 IPO9 UBR5 UTP20 PKN2 PRKDC NIPBL VARS1 HSPA8 HSPA9 | 2.09e-05 | 1353 | 163 | 19 | 29467282 |
| Pubmed | Targeting an Achilles' heel of cancer with a WRN helicase inhibitor. | 2.18e-05 | 2 | 163 | 2 | 24036544 | |
| Pubmed | Characterization of interleukin 2 stimulated 65-kilodalton phosphoprotein in human T cells. | 2.18e-05 | 2 | 163 | 2 | 2111166 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26890141 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24787902 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 32490574 | ||
| Pubmed | Identification of I-plastin, a human fimbrin isoform expressed in intestine and kidney. | 2.18e-05 | 2 | 163 | 2 | 8139549 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15664957 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 38253218 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 7639722 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16135554 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26344102 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 23948933 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 34375639 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26188124 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24595139 | ||
| Pubmed | CASP8AP2 HYOU1 MRPL12 SYNE1 CIP2A UBR4 GATB LRRC40 AP3B1 LCMT2 MXRA7 URB1 UBXN4 UBR5 TELO2 NUP210 TMED2 PKN2 HSPA8 HSPA9 | 2.32e-05 | 1487 | 163 | 20 | 33957083 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 2.64e-05 | 74 | 163 | 5 | 10817752 | |
| Pubmed | 3.20e-05 | 77 | 163 | 5 | 10835267 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 3.85e-05 | 80 | 163 | 5 | 10716726 | |
| Pubmed | 4.11e-05 | 41 | 163 | 4 | 32723828 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DNHD1 FLNA HYOU1 SYNE1 UBR4 LRRC40 MSH3 AP3B1 FANCD2 JARID2 URB1 IPO9 NUP210 UTP20 PRKDC NIPBL VARS1 HSPA8 HSPA9 | 4.23e-05 | 1425 | 163 | 19 | 30948266 |
| Pubmed | 4.41e-05 | 15 | 163 | 3 | 18303054 | ||
| Pubmed | 4.41e-05 | 15 | 163 | 3 | 17400507 | ||
| Pubmed | TRIM6 promotes colorectal cancer cells proliferation and response to thiostrepton by TIS21/FoxM1. | 4.98e-05 | 43 | 163 | 4 | 31992359 | |
| Pubmed | FLNA RIPOR2 PSAP HYOU1 CTC1 ASH1L PEX1 AP3B1 LCMT2 PPARGC1A URB1 SEPSECS TYW1B NFRKB LMBRD1 TRIM37 | 5.45e-05 | 1084 | 163 | 16 | 11544199 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M HYOU1 CIP2A UBR4 ARPC1B IPO9 UBR5 NUP210 PRKDC HSPA8 HSPA9 SEC23B | 5.88e-05 | 647 | 163 | 12 | 26618866 |
| Pubmed | 6.36e-05 | 210 | 163 | 7 | 16565220 | ||
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | SUPT20HL1 PCDHB6 GATB PEX1 SUPT20HL2 LARP4 ZBTB7A PKN2 PRKDC LCOR | 6.41e-05 | 457 | 163 | 10 | 32968282 |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24463883 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 28801652 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 7655078 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 28694070 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 37819742 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 8428952 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 27015186 | ||
| Pubmed | Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair. | 6.53e-05 | 3 | 163 | 2 | 25642963 | |
| Pubmed | HCLK2 is essential for the mammalian S-phase checkpoint and impacts on Chk1 stability. | 6.53e-05 | 3 | 163 | 2 | 17384638 | |
| Pubmed | Genome-wide association study in essential tremor identifies three new loci. | 6.53e-05 | 3 | 163 | 2 | 27797806 | |
| Pubmed | UBR E3 ligases and the PDIA3 protease control degradation of unfolded antibody heavy chain by ERAD. | 6.53e-05 | 3 | 163 | 2 | 32558906 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 9325337 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24625977 | ||
| Pubmed | Heat shock transcription factor 1 is SUMOylated in the activated trimeric state. | 6.53e-05 | 3 | 163 | 2 | 33493517 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 10878022 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 16520097 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 8940078 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 3211125 | ||
| Pubmed | Jarid2 regulates hematopoietic stem cell function by acting with polycomb repressive complex 2. | 6.53e-05 | 3 | 163 | 2 | 25645357 | |
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 24220028 | ||
| Pubmed | 6.53e-05 | 3 | 163 | 2 | 29274473 | ||
| Pubmed | Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin. | 7.63e-05 | 149 | 163 | 6 | 26370502 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | HYOU1 SCYL3 PEX1 PANX1 MXRA7 UBXN4 SLC41A3 NUP210 TMED2 SEC23B | 7.80e-05 | 468 | 163 | 10 | 31056421 |
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 7.83e-05 | 18 | 163 | 3 | 12119179 | |
| Pubmed | 8.52e-05 | 152 | 163 | 6 | 34299191 | ||
| Pubmed | 8.84e-05 | 153 | 163 | 6 | 10718198 | ||
| Pubmed | Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes. | 9.27e-05 | 19 | 163 | 3 | 20801936 | |
| Pubmed | 9.79e-05 | 225 | 163 | 7 | 12168954 | ||
| Pubmed | 1.06e-04 | 52 | 163 | 4 | 26499835 | ||
| Pubmed | 1.09e-04 | 20 | 163 | 3 | 22504172 | ||
| Pubmed | 1.13e-04 | 396 | 163 | 9 | 26687479 | ||
| Pubmed | Novel, gel-free proteomics approach identifies RNF5 and JAMP as modulators of GPCR stability. | 1.13e-04 | 160 | 163 | 6 | 23798571 | |
| Pubmed | 1.23e-04 | 54 | 163 | 4 | 35391932 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | FLNA HYOU1 MRPL12 UBR4 LRRC40 AP3B1 LARP4 ELP3 BIRC6 UBR5 PKN2 PRKDC HSF1 NIPBL VARS1 HSPA8 HSPA9 SEC23B | 1.23e-04 | 1415 | 163 | 18 | 28515276 |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 18414036 | ||
| Pubmed | A family of mammalian E3 ubiquitin ligases that contain the UBR box motif and recognize N-degrons. | 1.30e-04 | 4 | 163 | 2 | 16055722 | |
| Pubmed | Molecular chaperones as HSF1-specific transcriptional repressors. | 1.30e-04 | 4 | 163 | 2 | 9499401 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 19931244 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 36759517 | ||
| Pubmed | Androgen-induced cell migration: role of androgen receptor/filamin A association. | 1.30e-04 | 4 | 163 | 2 | 21359179 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 14993262 | ||
| Pubmed | LRF-mediated Dll4 repression in erythroblasts is necessary for hematopoietic stem cell maintenance. | 1.30e-04 | 4 | 163 | 2 | 23134786 | |
| Pubmed | αvβ5 Integrin/FAK/PGC-1α Pathway Confers Protective Effects on Retinal Pigment Epithelium. | 1.30e-04 | 4 | 163 | 2 | 26244551 | |
| Pubmed | HCLK2 is required for activity of the DNA damage response kinase ATR. | 1.30e-04 | 4 | 163 | 2 | 19097996 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 18191876 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 14756805 | ||
| Pubmed | FcγRIIb and BAFF differentially regulate peritoneal B1 cell survival. | 1.30e-04 | 4 | 163 | 2 | 22516957 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 2686960 | ||
| Pubmed | The substrate recognition domains of the N-end rule pathway. | 1.30e-04 | 4 | 163 | 2 | 19008229 | |
| Pubmed | Fidgetin-like 2 depletion enhances cell migration by regulating GEF-H1, RhoA, and FAK. | 1.30e-04 | 4 | 163 | 2 | 36523161 | |
| Pubmed | Identification of Filamin A as a BRCA1-interacting protein required for efficient DNA repair. | 1.30e-04 | 4 | 163 | 2 | 20305393 | |
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 26634371 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 10404183 | ||
| Pubmed | 1.30e-04 | 4 | 163 | 2 | 34943961 | ||
| Pubmed | 1.46e-04 | 22 | 163 | 3 | 15657067 | ||
| Interaction | PDGFRB interactions | 1.69e-06 | 228 | 156 | 11 | int:PDGFRB | |
| Interaction | HLA-B interactions | ABCA2 HLA-B PCDH20 FANCD2 TELO2 CLN3 PRKDC LCOR VARS1 HSPA8 MUSK | 2.66e-06 | 239 | 156 | 11 | int:HLA-B |
| GeneFamily | Solute carriers | SLC17A2 SLC34A3 SLC22A17 SLC9C1 SLC8A3 SLC25A43 SLC41A3 SLC18A3 SLC22A10 SLC36A3 SLC16A11 SLC51A | 3.47e-06 | 395 | 106 | 12 | 752 |
| GeneFamily | Heat shock 70kDa proteins | 1.25e-04 | 17 | 106 | 3 | 583 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 7.01e-04 | 7 | 106 | 2 | 785 | |
| GeneFamily | Ring finger proteins|Baculoviral IAP repeat containing|Caspase recruitment domain containing | 9.32e-04 | 8 | 106 | 2 | 419 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.65e-03 | 40 | 106 | 3 | 321 | |
| GeneFamily | Non-clustered protocadherins | 2.16e-03 | 12 | 106 | 2 | 21 | |
| GeneFamily | UBX domain containing | 2.55e-03 | 13 | 106 | 2 | 364 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.74e-08 | 135 | 163 | 8 | 3351e8b9e417397c5fa9f856184ff24ce1a27242 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 8.06e-08 | 149 | 163 | 8 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.03e-06 | 169 | 163 | 7 | 2e15a9317da4017757d184f7cc91bd66b072ac51 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-06 | 184 | 163 | 7 | d071f53ad9e957dc0f8ae9c53aaa31cfebcf815e | |
| ToppCell | COVID-19_Severe-gd_T|COVID-19_Severe / Disease condition and Cell class | 5.31e-06 | 184 | 163 | 7 | 791f1bcb954aadc63d4117c400537d036f68734d | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.90e-06 | 187 | 163 | 7 | 20b25b0d08550a1e8e997c5ce67d8e34bf7fc398 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 7.26e-06 | 193 | 163 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.26e-06 | 193 | 163 | 7 | 222829c30ebe47f0ed1e035897e3cd4be10b2a11 | |
| ToppCell | Monocytes|World / lung cells shred on cell class, cell subclass, sample id | 7.26e-06 | 193 | 163 | 7 | d66d3927f8fbe1544b5cfa5ee91a7f4a0ef1e810 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-Activated_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.51e-06 | 194 | 163 | 7 | e3705346755cbf65fc276d4d4fbee936ed6bb7bf | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 7.76e-06 | 195 | 163 | 7 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | COVID-19_Severe-CD8+_Tem|COVID-19_Severe / Disease condition and Cell class | 7.76e-06 | 195 | 163 | 7 | ff7ae62393e1c858a10592db8e6d9f36b8bae396 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.76e-06 | 195 | 163 | 7 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-gd_T|COVID-19_Severe / Disease group, lineage and cell class | 7.76e-06 | 195 | 163 | 7 | 9990440bda7fac5d00ef80444fab07459be625e1 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-06 | 196 | 163 | 7 | fe8d3f45a64323947c36b127355d5940eb56c0ca | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.03e-06 | 196 | 163 | 7 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-06 | 196 | 163 | 7 | 418e8e0a51c5cb60e3b903e7d2d800dc8b9f3d5c | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-06 | 196 | 163 | 7 | 581fc8c8d42005aacd7b401a2c9d1fc331fb4af7 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 8.03e-06 | 196 | 163 | 7 | 6beaf0c2799424c59819b286fbb5c1a83d85e4d1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-gd_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.03e-06 | 196 | 163 | 7 | c35f2349dfe35baa845f790b9f31673dceac54c0 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.03e-06 | 196 | 163 | 7 | 526d037bb12d81f1c235c60ddc787fbad0bbad77 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-06 | 198 | 163 | 7 | eae8c29d68cc94bfbd15e487ad855639c2a4fcc9 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-06 | 198 | 163 | 7 | 2f94fb4a1719d5adddb4fd3dfaf099ee2b642011 | |
| ToppCell | Smart-seq2-thymus_(Smart-seq2)-myeloid|thymus_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.57e-06 | 198 | 163 | 7 | 2e470249edc7cf85bed550795ff84cbef22895c0 | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_monocytic-monocyte-promonocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 8.57e-06 | 198 | 163 | 7 | ff634a17195d06a8614ed1c6564937d10ca5c00d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.57e-06 | 198 | 163 | 7 | 6d547122b8c4ddbdd0d3dae3bce4a125740d5457 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 199 | 163 | 7 | b01328a80db5bb088c44564cea0f6729b1a9805b | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 199 | 163 | 7 | 3d6fa56da7b6bc1e045f80ddfe460d2d5715567e | |
| ToppCell | 5'-GW_trimst-2-LymphNode|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 199 | 163 | 7 | 4a9ca133125dc25a06e7b1cfea15ecffa449c20e | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 199 | 163 | 7 | 45d0d275ffb4183e3e71f4701e121ef9853ebd10 | |
| ToppCell | 10x5'v1-week_12-13-Myeloid_monocytic-monocyte|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.86e-06 | 199 | 163 | 7 | 3a50ca40f6147fac7ce0d201717781d3939bbebe | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.86e-06 | 199 | 163 | 7 | da20998253ad08a4a127a98b991b26237edb61a2 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.15e-06 | 200 | 163 | 7 | 62868b0ba312e8b5ff3b2477a04d31aeac497b2b | |
| ToppCell | Control-PLT_3|Control / Disease Group and Platelet Clusters | 1.30e-05 | 140 | 163 | 6 | 82ea671f61d55f6896d903c5876b042e2f3385d6 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 149 | 163 | 6 | 4de52569611e63a780cde9bd111d6d9c11a05a11 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 149 | 163 | 6 | c957ac23ad6343eacce7e6be4a6d3ac043af4f86 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.66e-05 | 159 | 163 | 6 | 7ad3a91d29639b32f6264c91f401c14a35469ac0 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.96e-05 | 162 | 163 | 6 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.17e-05 | 164 | 163 | 6 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c09-SLC4A10|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.17e-05 | 164 | 163 | 6 | a5227971a71345854e0538e42da684de87febda0 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.17e-05 | 164 | 163 | 6 | 2c929996a19bbe29949010928001c277b5494a42 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-05 | 166 | 163 | 6 | 6a65dff1333f39ec8c584e6df04b8c1e7f1c8946 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Hematologic-proerythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.39e-05 | 166 | 163 | 6 | a1211afc1197d078eb3db0d0f788ecaf4419aa5b | |
| ToppCell | COVID-19_Mild-PLT_3|COVID-19_Mild / Disease Group and Platelet Clusters | 3.87e-05 | 170 | 163 | 6 | 5ac1252ae3c026a506cfe26e3d119276fe364661 | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-05 | 172 | 163 | 6 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | tumor_Lymph_Node_/_Brain-T/NK_cells-CD8+/CD4+_Mixed_Th|T/NK_cells / Location, Cell class and cell subclass | 4.27e-05 | 173 | 163 | 6 | 42c911ed16fabdabef063830e8407192d8bde950 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.70e-05 | 176 | 163 | 6 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | droplet-Marrow-nan-21m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.70e-05 | 176 | 163 | 6 | f7d8eb90489a6d22240179abeb0aa16ac24615d3 | |
| ToppCell | ILEUM-inflamed-(9)_Enteric_neurons|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.00e-05 | 178 | 163 | 6 | d9142151819afb0dc22bfb32a9c9dba5f553067d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.00e-05 | 178 | 163 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | LA-17._Lymphocyte|World / Chamber and Cluster_Paper | 5.00e-05 | 178 | 163 | 6 | 34ec499d03cc198cfefa19a724d4c81974052f65 | |
| ToppCell | ILEUM-inflamed-(9)_Neuro_cell|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.00e-05 | 178 | 163 | 6 | 611504b0a9e6318b18fba83787b03f9245c82252 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-05 | 180 | 163 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-05 | 180 | 163 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.33e-05 | 180 | 163 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 181 | 163 | 6 | 35eefd874a892eaf21f24fdce89e7ea3b8ee285f | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.49e-05 | 181 | 163 | 6 | e4c3e0eae9f21e78b5dd18cf017bd041ffc8c968 | |
| ToppCell | LA-17._Lymphocyte|LA / Chamber and Cluster_Paper | 5.49e-05 | 181 | 163 | 6 | 3fd9f805fa46141b0fa7023ee5d8688d338635d5 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 182 | 163 | 6 | 243c783675df495ea4112dbf710712c44ea6b4f1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.66e-05 | 182 | 163 | 6 | d7cce5dd7046f06bf40f00c9dbfa610722b03333 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.66e-05 | 182 | 163 | 6 | 18790a394dc32b3cef99cdbf826392c520e38b4a | |
| ToppCell | droplet-Marrow-nan-21m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 183 | 163 | 6 | 71ea92cd20683230af314ff883b2624bd68382e1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.84e-05 | 183 | 163 | 6 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | Monocytes-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.02e-05 | 184 | 163 | 6 | d15405bf2a121570f6044546e98927b10ecc4354 | |
| ToppCell | wk_20-22-Epithelial-PNS-intermediate_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.02e-05 | 184 | 163 | 6 | 4e3ba64692868563a579902aa9c6f88cab5bce26 | |
| ToppCell | facs-Bladder-nan-18m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 185 | 163 | 6 | 3e00879466e626aa8604efecfc4678d64f54dbfc | |
| ToppCell | facs-Bladder-nan-18m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 185 | 163 | 6 | 3dc5812c961ff209f197ff4cbfb90009c0537550 | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 6.39e-05 | 186 | 163 | 6 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-05 | 186 | 163 | 6 | 02fbb02c495e7d64c4ab50e42e5197782f2c0816 | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-05 | 187 | 163 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | Endothelial-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 6.58e-05 | 187 | 163 | 6 | febe0b99a6a815ce687160a0e7af55228b1d5beb | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.58e-05 | 187 | 163 | 6 | 4e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.58e-05 | 187 | 163 | 6 | be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4 | |
| ToppCell | Monocytes-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | 6.77e-05 | 188 | 163 | 6 | 756375cf9c9cccc4fb4a7f5e4756fa3fc36a7892 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Monocytes|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-05 | 189 | 163 | 6 | a010f3e4da6e9bb23b0b9a7f82ad5cee4e607ecd | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD4_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.98e-05 | 189 | 163 | 6 | 5c92516c3745ccbd480b15bb2b9077ab1d9ee5a0 | |
| ToppCell | Control-B_intermediate-6|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.98e-05 | 189 | 163 | 6 | 11cb9a16f1de8f60af2073ed7ea6d4f41c02f299 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 189 | 163 | 6 | ce5b3d53c9a5457a5a02b221dee18334b5eaf8b7 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.18e-05 | 190 | 163 | 6 | 57800d807785b9d539b47945a0a74631f5e88a06 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC-cycling_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.18e-05 | 190 | 163 | 6 | d4aefae2d3164db6a9e953c54af0151501e9d1da | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 7.39e-05 | 191 | 163 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.39e-05 | 191 | 163 | 6 | 5d6ef70cc15ec5e983a953e547e40f9c06e355fb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.39e-05 | 191 | 163 | 6 | 47156e5f1d790707f42f6283104a44b33af613e5 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.39e-05 | 191 | 163 | 6 | 1c7d31684654ca6a046d8cc816af1fdc42369c57 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.39e-05 | 191 | 163 | 6 | d60d81d2045c6e624bbc8b17e13a32f7921d969f | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.39e-05 | 191 | 163 | 6 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Monocytic-Non-classical_Monocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 7.39e-05 | 191 | 163 | 6 | 47a2afc4102199b4bc76bd01b2967c8016186462 | |
| ToppCell | PND07|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.61e-05 | 192 | 163 | 6 | 8171a60df481195c39a7f740effcae8e4deb6ca7 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.61e-05 | 192 | 163 | 6 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-05 | 193 | 163 | 6 | e1de67ddada87229f5db0ec193a6da8745a86a64 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Mesenchymal-choroid_plexus/mesenchymal-like_cells|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.83e-05 | 193 | 163 | 6 | b6f5a85210e60798205eaf5884cdb540f549d08a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.06e-05 | 194 | 163 | 6 | 24837a27b0041fe8c348225fa8b09b127d743603 | |
| ToppCell | Monocytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 8.06e-05 | 194 | 163 | 6 | ed14fbb3b4622798f8e02dc91bbe464a6fed8310 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.06e-05 | 194 | 163 | 6 | 4eef50c38e6edb2ef2cdcd14eb50805f6cd65bc8 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-05 | 195 | 163 | 6 | 4df004b8ca7669a57d85c6dffef5b82b4ea1dfdf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-05 | 195 | 163 | 6 | 9e49e59a20b1bbd6167d594c33ab6bdfe2c1ebaf | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.29e-05 | 195 | 163 | 6 | 412a9fcf9f075d97fae254bbd89774e4b1face07 | |
| ToppCell | control-Lymphocytic-CD8_T_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.29e-05 | 195 | 163 | 6 | 55b9052336cab3e769a126ecaeef267d8e7bcaa8 | |
| Disease | brain ischemia (biomarker_via_orthology) | 1.17e-06 | 102 | 155 | 7 | DOID:2316 (biomarker_via_orthology) | |
| Disease | mitral valve prolapse (is_implicated_in) | 1.17e-05 | 9 | 155 | 3 | DOID:988 (is_implicated_in) | |
| Disease | Tinnitus, wellbeing measurement | 1.20e-05 | 96 | 155 | 6 | EFO_0007869, HP_0000360 | |
| Disease | androsterone sulfate measurement | 2.66e-05 | 33 | 155 | 4 | EFO_0021117 | |
| Disease | Massive Hepatic Necrosis | 2.74e-05 | 2 | 155 | 2 | C0001364 | |
| Disease | obsolete_red blood cell distribution width | SLC17A2 GALP LCP1 IGFLR1 AP3B1 BIRC6 PTK2 PIGQ SUSD1 NUP210 NFRKB MAST1 UBXN2A PKN2 PNPLA3 PLS1 HSPA8 MUSK FRMD5 SEC23B | 2.77e-05 | 1347 | 155 | 20 | EFO_0005192 |
| Disease | phosphatidylcholine 36:3 measurement | 6.18e-05 | 15 | 155 | 3 | EFO_0010381 | |
| Disease | Spondyloepiphyseal Dysplasia | 7.57e-05 | 16 | 155 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 7.57e-05 | 16 | 155 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 7.57e-05 | 16 | 155 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 7.57e-05 | 16 | 155 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 7.57e-05 | 16 | 155 | 3 | C0025237 | |
| Disease | Van Buchem disease | 9.16e-05 | 17 | 155 | 3 | C0432272 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 1.30e-04 | 19 | 155 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 1.30e-04 | 19 | 155 | 3 | C0029422 | |
| Disease | Dyschondroplasias | 1.30e-04 | 19 | 155 | 3 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 1.52e-04 | 20 | 155 | 3 | C0026760 | |
| Disease | triacylglycerol 52:2 measurement | 2.03e-04 | 55 | 155 | 4 | EFO_0010414 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.33e-04 | 23 | 155 | 3 | C1335177 | |
| Disease | level of leukocyte immunoglobulin-like receptor subfamily B member 4 in blood serum | 2.71e-04 | 5 | 155 | 2 | OBA_2042200 | |
| Disease | level of prosaposin in blood serum | 2.71e-04 | 5 | 155 | 2 | OBA_2044552 | |
| Disease | Myasthenia Gravis | 4.06e-04 | 6 | 155 | 2 | C0026896 | |
| Disease | angiopoietin-1 receptor, soluble measurement | 4.06e-04 | 6 | 155 | 2 | EFO_0008023 | |
| Disease | Myasthenia Gravis, Ocular | 4.06e-04 | 6 | 155 | 2 | C0751340 | |
| Disease | Myasthenia Gravis, Generalized | 4.06e-04 | 6 | 155 | 2 | C0751339 | |
| Disease | X-23641 measurement | 5.66e-04 | 7 | 155 | 2 | EFO_0800854 | |
| Disease | Huntington's disease (implicated_via_orthology) | 6.31e-04 | 32 | 155 | 3 | DOID:12858 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_implicated_in) | 7.00e-04 | 76 | 155 | 4 | DOID:14330 (is_implicated_in) | |
| Disease | Disproportionate short stature | 7.36e-04 | 77 | 155 | 4 | C0878659 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 4 measurement | 7.52e-04 | 8 | 155 | 2 | EFO_0801768 | |
| Disease | Pena-Shokeir syndrome type I | 7.52e-04 | 8 | 155 | 2 | C1276035 | |
| Disease | neutropenia (is_implicated_in) | 7.52e-04 | 8 | 155 | 2 | DOID:1227 (is_implicated_in) | |
| Disease | Lung diseases | 7.72e-04 | 78 | 155 | 4 | C0024115 | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 9.63e-04 | 9 | 155 | 2 | C1846707 | |
| Disease | free cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 1.15e-03 | 303 | 155 | 7 | EFO_0004612, EFO_0020945 | |
| Disease | aseptic loosening, revision of total knee arthroplasty | 1.40e-03 | 42 | 155 | 3 | EFO_0010725, EFO_0020972 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.40e-03 | 42 | 155 | 3 | EFO_0008317, EFO_0008596, EFO_0020945 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.47e-03 | 157 | 155 | 5 | DOID:14330 (implicated_via_orthology) | |
| Disease | triacylglycerol 56:6 measurement | 1.50e-03 | 43 | 155 | 3 | EFO_0010433 | |
| Disease | immunoglobulin isotype switching measurement | 1.61e-03 | 44 | 155 | 3 | EFO_0010128 | |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0801493 | |
| Disease | granulins measurement | 1.75e-03 | 12 | 155 | 2 | EFO_0008141 | |
| Disease | cirrhosis of liver | 2.06e-03 | 13 | 155 | 2 | EFO_0001422 | |
| Disease | birth weight, pelvic organ prolapse | 2.19e-03 | 49 | 155 | 3 | EFO_0004344, EFO_0004710 | |
| Disease | Tobacco Dependence | 2.39e-03 | 14 | 155 | 2 | C0040332 | |
| Disease | Nicotine Dependence | 2.39e-03 | 14 | 155 | 2 | C0028043 | |
| Disease | Nicotine Use Disorder | 2.39e-03 | 14 | 155 | 2 | C0376384 | |
| Disease | liver neoplasm | 2.75e-03 | 15 | 155 | 2 | EFO_1001513 | |
| Disease | gamma-glutamylphenylalanine measurement | 2.75e-03 | 15 | 155 | 2 | EFO_0021142 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 2.75e-03 | 15 | 155 | 2 | OBA_2045165 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 2.75e-03 | 15 | 155 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | non-alcoholic fatty liver disease | 2.80e-03 | 182 | 155 | 5 | EFO_0003095 | |
| Disease | peripheral arterial disease | 2.90e-03 | 54 | 155 | 3 | EFO_0004265 | |
| Disease | Metastatic melanoma | 2.90e-03 | 54 | 155 | 3 | C0278883 | |
| Disease | Antithrombotic agent use measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0009925 | |
| Disease | ecosanoids measurement | 3.05e-03 | 55 | 155 | 3 | EFO_0020044 | |
| Disease | linoleic acid measurement | 3.08e-03 | 186 | 155 | 5 | EFO_0006807 | |
| Disease | lung small cell carcinoma (is_marker_for) | 3.13e-03 | 16 | 155 | 2 | DOID:5409 (is_marker_for) | |
| Disease | level of triacylglycerol (56:6) in blood serum | 3.13e-03 | 16 | 155 | 2 | OBA_2020007 | |
| Disease | diacylglycerol 36:2 measurement | 3.13e-03 | 16 | 155 | 2 | EFO_0010355 | |
| Disease | antihyperlipidemic drug use measurement | 3.22e-03 | 115 | 155 | 4 | EFO_0803367 | |
| Disease | cholesterol:total lipids ratio, high density lipoprotein cholesterol measurement | 3.47e-03 | 276 | 155 | 6 | EFO_0004612, EFO_0020943 | |
| Disease | omega-3 polyunsaturated fatty acid measurement | 3.53e-03 | 118 | 155 | 4 | EFO_0010119 | |
| Disease | respiratory symptom change measurement, response to placebo | 3.54e-03 | 17 | 155 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | glycoprotein measurement | 3.64e-03 | 119 | 155 | 4 | EFO_0004555 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 3.91e-03 | 60 | 155 | 3 | EFO_0022282 | |
| Disease | phosphatidylcholine 36:4 measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0010382 | |
| Disease | diacylglycerol 36:3 measurement | 3.97e-03 | 18 | 155 | 2 | EFO_0020062 | |
| Disease | non-alcoholic fatty liver disease (is_implicated_in) | 3.97e-03 | 18 | 155 | 2 | DOID:0080208 (is_implicated_in) | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.09e-03 | 61 | 155 | 3 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.19e-03 | 200 | 155 | 5 | EFO_0004611, EFO_0020945 | |
| Disease | APOE carrier status, dementia | 4.29e-03 | 62 | 155 | 3 | EFO_0007659, MONDO_0001627 | |
| Disease | peripheral neuropathy, response to docetaxel trihydrate | 4.42e-03 | 19 | 155 | 2 | EFO_0003100, GO_1902519 | |
| Disease | diacylglycerol 38:5 measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0020067 | |
| Disease | diacylglycerol 38:3 measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0020065 | |
| Disease | angiopoietin-1 receptor measurement | 4.42e-03 | 19 | 155 | 2 | EFO_0010600 | |
| Disease | triglycerides:total lipids ratio, high density lipoprotein cholesterol measurement | 4.74e-03 | 206 | 155 | 5 | EFO_0004612, EFO_0020947 | |
| Disease | coagulation factor V measurement | 4.90e-03 | 20 | 155 | 2 | EFO_0008087 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SAAEQELLLTLPSLE | 1066 | Q13075 | |
| ELLLTLPSLESLEVS | 1071 | Q13075 | |
| LTTTDLAALLPEALG | 311 | P59826 | |
| PDRLSLQLALTELET | 481 | Q9HCE6 | |
| NPLLLSSTTELIEEI | 581 | Q9NR48 | |
| LPSVLLELLSQSCLI | 4356 | Q9NR09 | |
| LLLLGTLTDLSADLE | 111 | Q2NKJ3 | |
| VLLLSFALIILPSIS | 326 | Q68CJ9 | |
| LLLSLLPVARASEAE | 21 | P32297 | |
| AVATLASETLPLLAL | 236 | O15143 | |
| PLTVLLLLASADSQA | 21 | P12318 | |
| LSTITLTILADNIPE | 3716 | Q8WXG9 | |
| PIALLPLSDTLSSLV | 256 | Q9Y2Z9 | |
| AADILVATLIIPFSL | 56 | P18089 | |
| VLLPASLASTSLAIL | 6 | Q8IVK1 | |
| VTPSALAELLDLLDS | 446 | O75879 | |
| DSITCLLSELPQLSL | 2096 | Q96M86 | |
| LLEDLAVSLTVPSPL | 1436 | Q9UKL3 | |
| FVTLDSNIPLDLLTL | 121 | Q96MT7 | |
| LVLLLLVLLPTDASV | 11 | P01023 | |
| LLDSITVPVARASIL | 486 | O00203 | |
| TATPALALVLLAVTL | 6 | Q8N436 | |
| LSLPDVLRISAVLED | 56 | Q9H095 | |
| DIATLLIPAITTADA | 2006 | P98160 | |
| LDIVLILTSAILLGS | 131 | A8MUP6 | |
| LTVLVLLPLESATAL | 201 | Q8N130 | |
| LLPLESATALLERLS | 206 | Q8N130 | |
| PALSSEALVRVLVLD | 541 | Q9Y5E7 | |
| EAQPTTLADAIILLT | 946 | O75808 | |
| FLSLTLSDLPVIDIL | 276 | Q9H790 | |
| TLTISLLDTSNLELP | 266 | Q9UM07 | |
| LRAASPIITLVALDE | 1021 | Q8TEM1 | |
| LLLPSALSEQTEALI | 426 | P20585 | |
| LDRETTPALLLLVEA | 1501 | Q96JQ0 | |
| SPSDSCLLLLDVLVL | 171 | Q8N6Y1 | |
| SSLLLAPALQLLLDT | 176 | Q8NCK7 | |
| SLLSLQTELLLDLVA | 56 | Q9Y4H4 | |
| SLLLEILLLESQASL | 381 | Q6P4R8 | |
| STTVLVLRLPDLALN | 501 | Q5IJ48 | |
| ILLLVEATSVLLPTD | 26 | Q5MY95 | |
| LLLPFSIISNEILLS | 76 | Q8WVP7 | |
| IALITSALLPVDIFL | 56 | Q9NUN5 | |
| ILELSISLPAETELT | 1301 | A9Z1Z3 | |
| IAPVLELADSSALLP | 691 | Q5JUK3 | |
| SSIALLAEAPTLPLI | 31 | O95972 | |
| VLLLLLSTLVIPSAA | 16 | Q9UK85 | |
| VDTLLSPTALIDSIL | 321 | Q00613 | |
| SISTSLPVLDLIDAI | 546 | Q14651 | |
| ISTSLPVLDLIDAIQ | 546 | P13796 | |
| VPLARSLQISEELLS | 151 | Q96JN0 | |
| LVPLLELACTDTHTL | 176 | A6NMZ5 | |
| ILDTLSPRLATALSE | 316 | Q9NST1 | |
| LILEEIFTSLARLPT | 1451 | Q6KC79 | |
| TALLSIQDLLLEELS | 986 | Q86UK5 | |
| AALRAPLDLTTILVS | 516 | P0C6S8 | |
| SLDLTLILIIALGSV | 711 | Q9P2E7 | |
| PLLLISLAFAQEISI | 46 | Q96RD7 | |
| PLVELACSDTSLLEL | 181 | Q8NGE1 | |
| DVTDVLLLDVTPLSL | 431 | P38646 | |
| LLLDVTPLSLGIETL | 436 | P38646 | |
| LLIDADLRITPAETL | 506 | Q9H422 | |
| PRTVLLLLSAALALT | 6 | P01889 | |
| PASLLELRALQTLSL | 136 | Q96CX6 | |
| EALPTEAQLLISSLL | 611 | Q9Y2H9 | |
| LSDLALTLPTDAVSI | 86 | Q86U44 | |
| EPALTATATVLLSLV | 656 | Q9Y5I0 | |
| ANLLAVLTETLDSLP | 86 | Q9UBK2 | |
| LGPVELALTSILTLL | 46 | Q86UW1 | |
| LSEELIASRLVPLLL | 281 | Q8IZE3 | |
| SDSFLDTTVPLLVLI | 386 | Q9UI47 | |
| LLVLLLSLAETPASA | 11 | Q9UBC7 | |
| LLLLIILTESDLDIA | 516 | Q7Z6J6 | |
| VLLADLLALSDTLAV | 21 | Q9Y4L1 | |
| RLVSAALVILSELPA | 1721 | Q86XA9 | |
| LAALDTLNPADISLV | 2771 | Q8TD57 | |
| PLLVLVVTALSTLLS | 446 | P56159 | |
| IPINISETDLSLLTA | 1971 | P21333 | |
| TSLVLLDLISEVPLR | 721 | O75417 | |
| AATLAVSPLLLVTIL | 61 | Q8TDV2 | |
| EASLLPLLSRELSSL | 231 | Q9H665 | |
| ELLLAPALLEQLTCT | 226 | Q9BZC7 | |
| VLRLSLSSESELPSL | 1166 | Q7Z591 | |
| SPSDLVELVARILAL | 341 | Q9H9T3 | |
| LTTDPDLILEVLRSS | 166 | Q71RC2 | |
| AISLLLLPEELELLS | 996 | Q6UXX5 | |
| VILADLNLSVSPFLL | 481 | Q96P70 | |
| SDLDPLILTLSLILV | 246 | P19235 | |
| STLLDALVLRNIEPI | 176 | Q86Z14 | |
| SVLLISELEALLPAR | 486 | A6NMB9 | |
| PSVLLAVELLSLLAD | 601 | Q8WXE1 | |
| LLASTLLALLVSPAR | 16 | O75629 | |
| LLLLSLGLVLAEASE | 6 | Q8TAA1 | |
| SLLELLELLLDASAL | 706 | P51172 | |
| LELLLDASALTLVLG | 711 | P51172 | |
| VSRLEILNVLSDSLP | 1011 | O43933 | |
| IDLETILLLNPALDS | 71 | Q8N4N8 | |
| LSDLLIENTSLTVPI | 231 | Q9BXW9 | |
| LTVPILDVLSSLRLD | 241 | Q9BXW9 | |
| TALDVLLELVVLNPS | 491 | Q9BXW9 | |
| SLTDDLRLLPALTVL | 96 | Q9H9A6 | |
| LTTPRLTLSELDDII | 541 | Q16363 | |
| LLLLDVTPLSLGIET | 391 | P11142 | |
| PTLSTISALLDELRD | 1076 | Q92833 | |
| SPALSSEALVRLLVL | 536 | Q9Y5E3 | |
| FNLALADTLVLLTLP | 91 | P41146 | |
| SPSLNVSLLLTLSIL | 146 | P03891 | |
| ESELSPFLITLILAV | 26 | P59534 | |
| APTLADLAAVTALLL | 156 | P26640 | |
| PLSAIAQLLSILTEV | 811 | Q5T011 | |
| ALADAIIELQLLPAS | 2381 | Q5T011 | |
| LLSLEESSELLHLVP | 571 | O75691 | |
| TDPLVSLENVLLTAL | 456 | Q9NUP7 | |
| AATSSLLDIDPLILI | 606 | O94972 | |
| LVDTALLPTLAFLVD | 396 | Q16572 | |
| VLLSLAEDVLTVSPA | 31 | Q13424 | |
| LESQLILATAEPLCL | 196 | Q3ZLR7 | |
| TILRSLTDAVPLSVL | 596 | Q9H5Y7 | |
| STEDLPEVILTLSLI | 11 | Q4G0N8 | |
| ILPSELSLQLAEVAL | 5391 | Q8NF91 | |
| AAILSTLLAAEVIPT | 426 | Q8WUG5 | |
| LLPFSIISNEVLLSL | 81 | Q6UX01 | |
| LLLPLLILCTVSVAS | 6 | P01718 | |
| ILSEDALLRISIPLD | 66 | Q63ZE4 | |
| ILEQLAELLPSVSSV | 551 | Q92696 | |
| LRTLLATVDETIPLL | 961 | Q05397 | |
| PICLLLASLLSLVSA | 211 | Q9BRB3 | |
| PAISLADSTDLRVLL | 206 | Q5VSL9 | |
| ELTISALSLALLVPV | 201 | Q8NG04 | |
| SVLLSLPAARLLEDL | 776 | Q9Y4R8 | |
| ASLGDLITLSILALV | 226 | Q96GZ6 | |
| AEVLATLPSLAIQSL | 141 | A6NM43 | |
| AEVLATLPSLAIQSL | 141 | Q96SF2 | |
| LAGTLSLSLTAPLEL | 21 | Q8WUT9 | |
| SLSLTAPLELATVLA | 26 | Q8WUT9 | |
| IIIEELSLVAASPTL | 291 | Q16513 | |
| ALLPTLAVDELDTVL | 1186 | O60287 | |
| LVSQILDRAEPLLSS | 861 | Q9Y4F9 | |
| PVLLDSSSILADRIL | 636 | Q15437 | |
| VSSSALALIIPALLE | 401 | Q495N2 | |
| LSDQPLLTSDLLSLL | 1071 | Q9NRP7 | |
| IASLTLLEISDLNEL | 71 | P52815 | |
| LESQLILATAEPLCL | 196 | P0C7V6 | |
| STAAVLLADILPTLV | 96 | Q13286 | |
| ELLEDPNISASLILS | 61 | Q8TCG1 | |
| DPALILAENASLLSL | 66 | Q7LGC8 | |
| SGLLEISAVPLSDLL | 176 | Q8N999 | |
| TLLLVSELGLDSEVL | 71 | P50336 | |
| LRALSSELPVVISLT | 566 | Q6UWL2 | |
| SLEVTDLLLTALENP | 236 | Q8IV42 | |
| LTLPSATCLELLLIL | 351 | Q7Z6J8 | |
| LVLSSNVPLLALEFL | 41 | Q86VQ3 | |
| LLISSLLTLFTPLAA | 126 | O00624 | |
| SLATALPVLRLLDET | 216 | P68543 | |
| LVADLLLLSSEARPV | 46 | Q9H1K6 | |
| TSLLSLDLIEPLLQL | 376 | Q96DC7 | |
| LILINSLPLVSDAET | 26 | Q02763 | |
| SSILSILLEEVSPEL | 366 | P07602 | |
| ERLVSLLLNPAVLST | 1526 | P78527 | |
| ELLVLLAALLATVSG | 6 | Q15363 | |
| LVLDLAQARSTLVLP | 106 | Q8N398 | |
| LILPESLSLLTFEDV | 226 | P51815 | |
| ASPSLDVLITLLSLG | 316 | Q9HD40 | |
| RASTALLLPILLTTE | 231 | Q9Y4F4 | |
| SPTLLLAEAVLTYLE | 181 | O60294 | |
| IRTLLPLLLESSTES | 1311 | Q5T4S7 | |
| LDLELAPSASVVLLP | 381 | Q92575 | |
| LLAALASLLLPESAA | 26 | Q06418 | |
| LAEAVTSLDLPVAII | 51 | Q6NUM6 | |
| DILSAARLLEIPAVS | 106 | O95365 | |
| LELSPAQLLLLLASE | 2421 | O95071 | |
| LSLSSEDPVLTALEL | 231 | Q9HCX4 | |
| LGSSAPEILLSLIEV | 141 | P57103 | |
| ELLAALPALATALAL | 6 | P84157 | |
| SAAVTLTTLPSELLL | 531 | O15146 |